Please Wait
Applying Filters...
menu
    • menu
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Evonik

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Biguanide

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    $ API Ref.Price (USD/KG) : 19Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 8Metgluco

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Metgluco

    Biguanide

    arrow
    Arvo
    Not Confirmed

    Brand Name : Metgluco

    U.S.A
    arrow
    Arvo
    Not Confirmed

    Dainippon Sumitomo

    Biguanide

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2020 Revenue in Millions : 91

    2019 Revenue in Millions : 93

    Growth (%) : -3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Metgluco

    Biguanide

    arrow
    Arvo
    Not Confirmed

    Brand Name : Metgluco

    U.S.A
    arrow
    Arvo
    Not Confirmed

    Dainippon Sumitomo

    Biguanide

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2021 Revenue in Millions : 69

    2020 Revenue in Millions : 91

    Growth (%) : -13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Metgluco

    Biguanide

    arrow
    Arvo
    Not Confirmed

    Brand Name : Metgluco

    U.S.A
    arrow
    Arvo
    Not Confirmed

    Dainippon Sumitomo

    Biguanide

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2022 Revenue in Millions : 60

    2021 Revenue in Millions : 69

    Growth (%) : -13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Metgluco

    Biguanide Hydrochloride

    arrow
    Arvo
    Not Confirmed

    Brand Name : Metgluco

    U.S.A
    arrow
    Arvo
    Not Confirmed

    Dainippon Sumitomo

    Biguanide Hydrochloride

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2023 Revenue in Millions : 50

    2022 Revenue in Millions : 60

    Growth (%) : -5

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Metgluco

    Biguanide

    arrow
    Arvo
    Not Confirmed

    Brand Name : Metgluco

    Japan
    arrow
    Arvo
    Not Confirmed

    Dainippon Sumitomo

    Biguanide

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2016 Revenue in Millions : 103

    2015 Revenue in Millions : 147

    Growth (%) : -30

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Metgluco

    Biguanide

    arrow
    Arvo
    Not Confirmed

    Brand Name : Metgluco

    Japan
    arrow
    Arvo
    Not Confirmed

    Dainippon Sumitomo

    Biguanide

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2017 Revenue in Millions : 109

    2016 Revenue in Millions : 111

    Growth (%) : -2

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Metgluco

    Biguanide

    arrow
    Arvo
    Not Confirmed

    Brand Name : Metgluco

    Japan
    arrow
    Arvo
    Not Confirmed

    Dainippon Sumitomo

    Biguanide

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2018 Revenue in Millions : 92

    2017 Revenue in Millions : 98

    Growth (%) : -6%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Metgluco

    Biguanide

    arrow
    Arvo
    Not Confirmed

    Brand Name : Metgluco

    U.S.A
    arrow
    Arvo
    Not Confirmed

    Dainippon Sumitomo

    Biguanide

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2019 Revenue in Millions : 90

    2018 Revenue in Millions : 95

    Growth (%) : -5

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF